Boston's Life Science Disruptors
Wednesday, October 17, 2018 at 6:00pm to 7:45pm
Koch Institute for Integrative Cancer Research (500 Main St, Cambridge, MA 02142)
Join Xconomy for this unique event featuring candid stories from some of New England's most radical biotech company leaders, founders, and VC backers out to change the game in life sciences.
Innovation is moving fast in biotech, and look no further than some of Boston’s latest emerging companies for proof. Beam Therapeutics, for instance, is taking CRISPR gene editing to the next level. Celsius Therapeutics is using machine learning algorithms to drill down into the genomic blueprint of single cells in search of a better understanding of why various diseases begin. And Arrakis Therapeutics is one of several new companies trying to target disease-causing RNA molecules with chemical drugs. How do disruptive visions like these come together and take shape within a company? How do their founders and investors turn these ideas into a business? And most importantly, how will their work impact the lives and health of patients?
-
Biotech leaders and investors, including:
-
David Liu, Co-Founder, Beam Therapeutics; Faculty Vice-Chair, Broad Institute
-
John Evans, CEO & Board Member, Beam Therapeutics
-
Aviv Regev, Scientific Founder, Celsius Therapeutics; Faculty Chair and Core Member, Broad Institute
-
Alexis Borisy, Chair, Celsius Therapeutics; Partner, Third Rock Ventures
-
Christoph Lengauer, President, Celsius Therapeutics
-
Jennifer Petter, Founder & Chief Scientific Officer, Arrakis Therapeutics
-
Michael Gilman, CEO, Arrakis Therapeutics
-
Enter code MITevents to qualify for a $25 discount.
- Event Type
- Events By Interest
- Events By Audience
- Website
- Department
- Koch Institute for Integrative Cancer Research
- Hashtag
- Contact Email
- Add to my calendar
Recent Activity
No recent activity